120 results on '"Gearhart JD"'
Search Results
2. Cell-based interventions for neurologic conditions
- Author
-
Mathews, DJH, Sugarman, J, Bok, H, Blass, DM, Coyle, JT, Duggan, P, Finkel, J, Greely, HT, Hillis, A, Hoke, A, Johnson, R, Johnson, M, Kahn, J, Kerr, D, Kurtzberg, J, Liao, SM, Mcdonald, JW, McKhann, G, Nelson, KB, Rao, M, Regenberg, A, Siegel, AW, Smith, K, Solter, D, Song, H, Young, W, Gearhart, JD, Faden, R., VESCOVI, ANGELO LUIGI, Mathews, D, Sugarman, J, Bok, H, Blass, D, Coyle, J, Duggan, P, Finkel, J, Greely, H, Hillis, A, Hoke, A, Johnson, R, Johnson, M, Kahn, J, Kerr, D, Kurtzberg, J, Liao, S, Mcdonald, J, Mckhann, G, Nelson, K, Rao, M, Regenberg, A, Siegel, A, Smith, K, Solter, D, Song, H, Vescovi, A, Young, W, Gearhart, J, and Faden, R
- Subjects
cell-based interventions - Abstract
Background: Attempts to translate basic stem cell research into treatments for neurologic diseases and injury are well under way. With a clinical trial for one such treatment approved and in progress in the United States, and additional proposals under review, we must begin to address the ethical issues raised by such early forays into human clinical trials for cell-based interventions for neurologic conditions. Methods: An interdisciplinary working group composed of experts in neuroscience, cell biology, bioethics, law, and transplantation, along with leading disease researchers, was convened twice over 2 years to identify and deliberate on the scientific and ethical issues raised by the transition from preclinical to clinical research of cell-based interventions for neurologic conditions. Results: While the relevant ethical issues are in many respects standard challenges of human subjects research, they are heightened in complexity by the novelty of the science, the focus on the CNS, and the political climate in which the science is proceeding. Conclusions: Distinctive challenges confronting US scientists, administrators, institutional review boards, stem cell research oversight committees, and others who will need to make decisions about work involving stem cells and their derivatives and evaluate the ethics of early human trials include evaluating the risks, safety, and benefits of these trials, determining and evaluating cell line provenance, and determining inclusion criteria, informed consent, and the ethics of conducting early human trials in the public spotlight. Further study and deliberation by stakeholders is required to move toward professional and institutional policies and practices governing this research. Copyright © 2008 by AAN Enterprises, Inc.
- Published
- 2008
3. Identification of RNA binding motif proteins essential for cardiovascular development
- Author
-
Maragh, S, Miller, RA, Bessling, SL, McGaughey, DM, Wessels, Marja, de Graaf, Bianca, Stone, EA, Bertoli Avella, AM, Gearhart, JD, Fisher, S, McCallion, AS, Maragh, S, Miller, RA, Bessling, SL, McGaughey, DM, Wessels, Marja, de Graaf, Bianca, Stone, EA, Bertoli Avella, AM, Gearhart, JD, Fisher, S, and McCallion, AS
- Abstract
Background: We recently identified Rbm24 as a novel gene expressed during mouse cardiac development. Due to its tightly restricted and persistent expression from formation of the cardiac crescent onwards and later in forming vasculature we posited it to be a key player in cardiogenesis with additional roles in vasculogenesis and angiogenesis. Results: To determine the role of this gene in cardiac development, we have identified its zebrafish orthologs (rbm24a and rbm24b), and functionally evaluated them during zebrafish embryogenesis. Consistent with our underlying hypothesis, reduction in expression of either ortholog through injection of morpholino antisense oligonucleotides results in cardiogenic defects including cardiac looping and reduced circulation, leading to increasing pericardial edema over time. Additionally, morphant embryos for either ortholog display incompletely overlapping defects in the forming vasculature of the dorsal aorta (DA), posterior caudal vein (PCV) and caudal vein (CV) which are the first blood vessels to form in the embryo. Vasculogenesis and early angiogenesis in the trunk were similarly compromised in rbm24 morphant embryos at 48 hours post fertilization (hpf). Subsequent vascular maintenance was impaired in both rbm24 morphants with substantial vessel degradation noted at 72 hpf. Conclusion: Taken collectively, our functional data support the hypothesis that rbm24a and rbm24b are key developmental cardiac genes with unequal roles in cardiovascular formation.
- Published
- 2011
4. Unintended changes in cognition, mood, and behavior arising from cell-based interventions for neurological conditions: Ethical challenges
- Author
-
Duggan, P, Siegel, A, Blass, D, Bok, H, Coyle, J, Faden, R, Finkel, J, Gearhart, J, Greely, H, Hillis, A, Hoke, A, Johnson, R, Johnston, M, Kahn, J, Kerr, D, King, P, Kurtzberg, J, Liao, S, Mcdonald, J, Mckhann, G, Nelson, K, Rao, M, Regenberg, A, Smith, K, Solter, D, Song, H, Sugarman, J, Traystman, R, Vescovi, A, Yanofski, J, Young, W, Mathews, D, Duggan, PS, Siegel, AW, Blass, DM, Coyle, JT, Gearhart, JD, Greely, HT, Liao, SM, McDonald, JW, McKhann, G, Nelson, KB, Traystman, RJ, Mathews, DJ, VESCOVI, ANGELO LUIGI, Duggan, P, Siegel, A, Blass, D, Bok, H, Coyle, J, Faden, R, Finkel, J, Gearhart, J, Greely, H, Hillis, A, Hoke, A, Johnson, R, Johnston, M, Kahn, J, Kerr, D, King, P, Kurtzberg, J, Liao, S, Mcdonald, J, Mckhann, G, Nelson, K, Rao, M, Regenberg, A, Smith, K, Solter, D, Song, H, Sugarman, J, Traystman, R, Vescovi, A, Yanofski, J, Young, W, Mathews, D, Duggan, PS, Siegel, AW, Blass, DM, Coyle, JT, Gearhart, JD, Greely, HT, Liao, SM, McDonald, JW, McKhann, G, Nelson, KB, Traystman, RJ, Mathews, DJ, and VESCOVI, ANGELO LUIGI
- Abstract
The prospect of using cell-based interventions (CBIs) to treat neurological conditions raises several important ethical and policy questions. In this target article, we focus on issues related to the unique constellation of traits that characterize CBIs targeted at the central nervous system. In particular, there is at least a theoretical prospect that these cells will alter the recipients' cognition, mood, and behavior-brain functions that are central to our concept of the self. The potential for such changes, although perhaps remote, is cause for concern and careful ethical analysis. Both to enable better informed consent in the future and as an end in itself, we argue that early human trials of CBIs for neurological conditions must monitor subjects for changes in cognition, mood, and behavior; further, we recommend concrete steps for that monitoring. Such steps will help better characterize the potential risks and benefits of CBIs as they are tested and potentially used for treatment. © Taylor & Francis Group, LLC.
- Published
- 2009
5. The role of animal models in evaluating reasonable and efficacy for human trials of cell-based interventions for neurologic conditions”
- Author
-
Regenberg, A, Mathews, D, Blass, D, Bok, H, Coyle, J, Duggan, P, Faden, R, Finkel, J, Gearhart, J, Hillis, A, Hoke, A, Johnson, R, Johnston, M, Kahn, J, Kerr, D, King, P, Kurtzberg, J, Liao, S, Mcdonald, J, Mckhann, G, Nelson, K, Rao, M, Siegel, A, Smith, K, Solter, D, Song, H, Sugarman, J, Vescovi, A, Young, W, Greely, H, Traystman, R, Mathews, DJ, Blass, DM, Coyle, JT, Gearhart, JD, Liao, SM, McDonald, JW, McKhann, G, Nelson, KB, Siegel, AW, Greely, HT, Traystman, RJ, VESCOVI, ANGELO LUIGI, Regenberg, A, Mathews, D, Blass, D, Bok, H, Coyle, J, Duggan, P, Faden, R, Finkel, J, Gearhart, J, Hillis, A, Hoke, A, Johnson, R, Johnston, M, Kahn, J, Kerr, D, King, P, Kurtzberg, J, Liao, S, Mcdonald, J, Mckhann, G, Nelson, K, Rao, M, Siegel, A, Smith, K, Solter, D, Song, H, Sugarman, J, Vescovi, A, Young, W, Greely, H, Traystman, R, Mathews, DJ, Blass, DM, Coyle, JT, Gearhart, JD, Liao, SM, McDonald, JW, McKhann, G, Nelson, KB, Siegel, AW, Greely, HT, Traystman, RJ, and VESCOVI, ANGELO LUIGI
- Abstract
Progress in regenerative medicine seems likely to produce new treatments for neurologic conditions that use human cells as therapeutic agents; at least one trial for such an intervention is already under way. The development of cell-based interventions for neurologic conditions (CBI-NCs) will likely include preclinical studies using animals as models for humans with conditions of interest. This paper explores predictive validity challenges and the proper role for animal models in developing CBI-NCs. In spite of limitations, animal models are and will remain an essential tool for gathering data in advance of first-in-human clinical trials. The goal of this paper is to provide a realistic lens for viewing the role of animal models in the context of CBI-NCs and to provide recommendations for moving forward through this challenging terrain. © 2009 ISCBFM All rights reserved.
- Published
- 2009
6. Cell-based interventions for neurologic conditions
- Author
-
Mathews, D, Sugarman, J, Bok, H, Blass, D, Coyle, J, Duggan, P, Finkel, J, Greely, H, Hillis, A, Hoke, A, Johnson, R, Johnson, M, Kahn, J, Kerr, D, Kurtzberg, J, Liao, S, Mcdonald, J, Mckhann, G, Nelson, K, Rao, M, Regenberg, A, Siegel, A, Smith, K, Solter, D, Song, H, Vescovi, A, Young, W, Gearhart, J, Faden, R, Mathews, DJH, Blass, DM, Coyle, JT, Greely, HT, Liao, SM, Mcdonald, JW, McKhann, G, Nelson, KB, Siegel, AW, Gearhart, JD, Faden, R., VESCOVI, ANGELO LUIGI, Mathews, D, Sugarman, J, Bok, H, Blass, D, Coyle, J, Duggan, P, Finkel, J, Greely, H, Hillis, A, Hoke, A, Johnson, R, Johnson, M, Kahn, J, Kerr, D, Kurtzberg, J, Liao, S, Mcdonald, J, Mckhann, G, Nelson, K, Rao, M, Regenberg, A, Siegel, A, Smith, K, Solter, D, Song, H, Vescovi, A, Young, W, Gearhart, J, Faden, R, Mathews, DJH, Blass, DM, Coyle, JT, Greely, HT, Liao, SM, Mcdonald, JW, McKhann, G, Nelson, KB, Siegel, AW, Gearhart, JD, Faden, R., and VESCOVI, ANGELO LUIGI
- Abstract
Background: Attempts to translate basic stem cell research into treatments for neurologic diseases and injury are well under way. With a clinical trial for one such treatment approved and in progress in the United States, and additional proposals under review, we must begin to address the ethical issues raised by such early forays into human clinical trials for cell-based interventions for neurologic conditions. Methods: An interdisciplinary working group composed of experts in neuroscience, cell biology, bioethics, law, and transplantation, along with leading disease researchers, was convened twice over 2 years to identify and deliberate on the scientific and ethical issues raised by the transition from preclinical to clinical research of cell-based interventions for neurologic conditions. Results: While the relevant ethical issues are in many respects standard challenges of human subjects research, they are heightened in complexity by the novelty of the science, the focus on the CNS, and the political climate in which the science is proceeding. Conclusions: Distinctive challenges confronting US scientists, administrators, institutional review boards, stem cell research oversight committees, and others who will need to make decisions about work involving stem cells and their derivatives and evaluate the ethics of early human trials include evaluating the risks, safety, and benefits of these trials, determining and evaluating cell line provenance, and determining inclusion criteria, informed consent, and the ethics of conducting early human trials in the public spotlight. Further study and deliberation by stakeholders is required to move toward professional and institutional policies and practices governing this research. Copyright © 2008 by AAN Enterprises, Inc.
- Published
- 2008
7. Special Cells, Special Considerations: The Challenges of Bringing Embryonic Stem Cells From the Laboratory to the Clinic
- Author
-
Addis, RC, primary, Bulte, JWM, additional, and Gearhart, JD, additional
- Published
- 2008
- Full Text
- View/download PDF
8. Honoring the work and life of Leroy C. Stevens. A symposium as part of the International Stem Cell Initiative Workshop.
- Author
-
Graham CF, Solter D, Gearhart JD, Nadeau JH, and Knowles BB
- Subjects
- History, 20th Century, Humans, United States, Cell Differentiation, Pluripotent Stem Cells, Regenerative Medicine
- Abstract
In 2016, a symposium was convened in Leroy C. Stevens' honor, in association with a meeting of the International Stem Cell Initiative (ISCI). ISCI, funded internationally, is composed of a group of ~100 scientists from many countries, under the leadership of Peter Andrews, who have worked together to characterize a significant number of human pluripotent stem cell lines, to monitor their genetic stability and their differentiation into mature cell types and tissues in vitro and in vivo. Those at the ISCI meeting puzzled through one of the thorniest problems in the therapeutic use of the differentiated derivatives of pluripotent stem cells for human therapy; namely, pluripotent stem cells can differentiate into any cell type in the adult organism, but they also have the capacity for unlimited self-renewal, hence if mutated they may have tumorigenic potential. The meeting considered how these cells might become genetically or epigenetically abnormal and how the safety of these cells for human therapeutic uses could be assessed and assured. The symposium was an opportunity to pay tribute to Leroy Stevens and to the basic science origins of this newest aspect of regenerative medicine. It was a time to reflect on the past and on how it can influence the future of our field.
- Published
- 2016
- Full Text
- View/download PDF
9. Direct Reprogramming of Human Primordial Germ Cells into Induced Pluripotent Stem Cells: Efficient Generation of Genetically Engineered Germ Cells.
- Author
-
Bazley FA, Liu CF, Yuan X, Hao H, All AH, De Los Angeles A, Zambidis ET, Gearhart JD, and Kerr CL
- Subjects
- Cells, Cultured, Embryonic Stem Cells metabolism, Germ Cells metabolism, Humans, Induced Pluripotent Stem Cells metabolism, Kruppel-Like Factor 4, Kruppel-Like Transcription Factors genetics, Kruppel-Like Transcription Factors metabolism, Octamer Transcription Factor-3 genetics, Octamer Transcription Factor-3 metabolism, Proto-Oncogene Proteins c-myc genetics, Proto-Oncogene Proteins c-myc metabolism, SOXB1 Transcription Factors genetics, SOXB1 Transcription Factors metabolism, Cellular Reprogramming, Embryonic Stem Cells cytology, Germ Cells cytology, Induced Pluripotent Stem Cells cytology
- Abstract
Primordial germ cells (PGCs) share many properties with embryonic stem cells (ESCs) and innately express several key pluripotency-controlling factors, including OCT4, NANOG, and LIN28. Therefore, PGCs may provide a simple and efficient model for studying somatic cell reprogramming to induced pluripotent stem cells (iPSCs), especially in determining the regulatory mechanisms that fundamentally define pluripotency. Here, we report a novel model of PGC reprogramming to generate iPSCs via transfection with SOX2 and OCT4 using integrative lentiviral. We also show the feasibility of using nonintegrative approaches for generating iPSC from PGCs using only these two factors. We show that human PGCs express endogenous levels of KLF4 and C-MYC protein at levels similar to embryonic germ cells (EGCs) but lower levels of SOX2 and OCT4. Transfection with both SOX2 and OCT4 together was required to induce PGCs to a pluripotent state at an efficiency of 1.71%, and the further addition of C-MYC increased the efficiency to 2.33%. Immunohistochemical analyses of the SO-derived PGC-iPSCs revealed that these cells were more similar to ESCs than EGCs regarding both colony morphology and molecular characterization. Although leukemia inhibitory factor (LIF) was not required for the generation of PGC-iPSCs like EGCs, the presence of LIF combined with ectopic exposure to C-MYC yielded higher efficiencies. Additionally, the SO-derived PGC-iPSCs exhibited differentiation into representative cell types from all three germ layers in vitro and successfully formed teratomas in vivo. Several lines were generated that were karyotypically stable for up to 24 subcultures. Their derivation efficiency and survival in culture significantly supersedes that of EGCs, demonstrating their utility as a powerful model for studying factors regulating pluripotency in future studies.
- Published
- 2015
- Full Text
- View/download PDF
10. In Memory of Bruce Wallace: 1920–2015.
- Author
-
MacIntyre RJ, Gearhart JD, Effron JW, O' Brien SJ, and Fogleman J
- Subjects
- Animals, Drosophila melanogaster genetics, Genetics, Population, History, 20th Century, History, 21st Century, Genetics history
- Published
- 2015
- Full Text
- View/download PDF
11. Early intervention for spinal cord injury with human induced pluripotent stem cells oligodendrocyte progenitors.
- Author
-
All AH, Gharibani P, Gupta S, Bazley FA, Pashai N, Chou BK, Shah S, Resar LM, Cheng L, Gearhart JD, and Kerr CL
- Subjects
- Animals, Axons physiology, Cell Differentiation, Cell Survival, Cells, Cultured, Early Medical Intervention, Female, Humans, Motor Activity, Myelin Sheath physiology, Nerve Regeneration, Oligodendroglia physiology, Rats, Inbred Lew, Recovery of Function, Spinal Cord pathology, Spinal Cord physiopathology, Treatment Outcome, Induced Pluripotent Stem Cells transplantation, Neural Stem Cells transplantation, Spinal Cord Injuries therapy
- Abstract
Induced pluripotent stem (iPS) cells are at the forefront of research in regenerative medicine and are envisaged as a source for personalized tissue repair and cell replacement therapy. Here, we demonstrate for the first time that oligodendrocyte progenitors (OPs) can be derived from iPS cells generated using either an episomal, non-integrating plasmid approach or standard integrating retroviruses that survive and differentiate into mature oligodendrocytes after early transplantation into the injured spinal cord. The efficiency of OP differentiation in all 3 lines tested ranged from 40% to 60% of total cells, comparable to those derived from human embryonic stem cells. iPS cell lines derived using episomal vectors or retroviruses generated a similar number of early neural progenitors and glial progenitors while the episomal plasmid-derived iPS line generated more OPs expressing late markers O1 and RIP. Moreover, we discovered that iPS-derived OPs (iPS-OPs) engrafted 24 hours following a moderate contusive spinal cord injury (SCI) in rats survived for approximately two months and that more than 70% of the transplanted cells differentiated into mature oligodendrocytes that expressed myelin associated proteins. Transplanted OPs resulted in a significant increase in the number of myelinated axons in animals that received a transplantation 24 h after injury. In addition, nearly a 5-fold reduction in cavity size and reduced glial scarring was seen in iPS-treated groups compared to the control group, which was injected with heat-killed iPS-OPs. Although further investigation is needed to understand the mechanisms involved, these results provide evidence that patient-specific, iPS-derived OPs can survive for three months and improve behavioral assessment (BBB) after acute transplantation into SCI. This is significant as determining the time in which stem cells are injected after SCI may influence their survival and differentiation capacity.
- Published
- 2015
- Full Text
- View/download PDF
12. Inhibition of TGFβ signaling increases direct conversion of fibroblasts to induced cardiomyocytes.
- Author
-
Ifkovits JL, Addis RC, Epstein JA, and Gearhart JD
- Subjects
- Animals, Benzamides pharmacology, Cell Differentiation, Dioxoles pharmacology, Fibroblasts drug effects, Mice, Signal Transduction drug effects, Transcription Factors metabolism, Fibroblasts physiology, Myocytes, Cardiac physiology, Receptors, Transforming Growth Factor beta antagonists & inhibitors, Transforming Growth Factor beta antagonists & inhibitors
- Abstract
Recent studies have been successful at utilizing ectopic expression of transcription factors to generate induced cardiomyocytes (iCMs) from fibroblasts, albeit at a low frequency in vitro. This work investigates the influence of small molecules that have been previously reported to improve differentiation to cardiomyocytes as well as reprogramming to iPSCs in conjunction with ectopic expression of the transcription factors Hand2, Nkx2.5, Gata4, Mef2C, and Tbx5 on the conversion to functional iCMs. We utilized a reporter system in which the calcium indicator GCaMP is driven by the cardiac Troponin T promoter to quantify iCM yield. The TGFβ inhibitor, SB431542 (SB), was identified as a small molecule capable of increasing the conversion of both mouse embryonic fibroblasts and adult cardiac fibroblasts to iCMs up to ∼5 fold. Further characterization revealed that inhibition of TGFβ by SB early in the reprogramming process led to the greatest increase in conversion of fibroblasts to iCMs in a dose-responsive manner. Global transcriptional analysis at Day 3 post-induction of the transcription factors revealed an increased expression of genes associated with the development of cardiac muscle in the presence of SB compared to the vehicle control. Incorporation of SB in the reprogramming process increases the efficiency of iCM generation, one of the major goals necessary to enable the use of iCMs for discovery-based applications and for the clinic.
- Published
- 2014
- Full Text
- View/download PDF
13. Optimal isolation and xeno-free culture conditions for limbal stem cell function.
- Author
-
Stasi K, Goings D, Huang J, Herman L, Pinto F, Addis RC, Klein D, Massaro-Giordano G, and Gearhart JD
- Subjects
- Adult, Aged, Animals, Cell Differentiation, Cell Proliferation, Cells, Cultured, Coculture Techniques, Culture Media, Conditioned, Female, Follow-Up Studies, Humans, Immunohistochemistry, Limbus Corneae metabolism, Male, Mice, Middle Aged, Oxygen metabolism, Xenobiotics, Limbus Corneae cytology, Stem Cells physiology
- Abstract
Purpose: To preserve limbal stem cell (LSC) function in vitro with xenobiotic-free culture conditions., Methods: Limbal epithelial cells were isolated from 139 donors using 15 variations of three dissociation solutions. All culture conditions were compared to the baseline condition of murine 3T3-J3 feeders with xenobiotic (Xeno) keratinocyte growth medium at 20% O2. Five Xeno and Xeno-free media with increasing concentrations of calcium and epidermal growth factor (EGF) were evaluated at 5%, 14%, and 20% O2. Human MRC-5, dermal (fetal, neonatal, or adult), and limbal stromal fibroblasts were compared. Statistical analysis was performed on the number of maximum serial weekly passages, percentage of aborted colonies, colony-forming efficiency (CFE), p63α(bright) cells, and RT-PCR ratio of p63α/K12. Immunocytochemistry and RT-PCR for p63α, ABCG2, Bmi1, C/EBPδ , K12, and MUC1 were performed to evaluate phenotype., Results: Dispase/TrypLE was the isolation method that consistently showed the best yield, viability, and CFE. On 3T3-J2 feeders, Xeno-free medium with calcium 0.1 mM and EGF 10 ng/mL at 20% O2 supported more passages with equivalent percentage of aborted colonies, p63α(bright) cells, and p63α/K12 RT-PCR ratio compared to baseline Xeno-media. With this Xeno-free medium, MRC-5 feeders showed the best performance, followed by fetal, neonatal, adult HDF, and limbal fibroblasts. MRC-5 feeders supported serial passages with sustained high expression of progenitor cell markers at levels as robust as the baseline condition without significant difference between 20% and 5% O2., Conclusions: The LSC function can be maintained in vitro under appropriate Xeno-free conditions.
- Published
- 2014
- Full Text
- View/download PDF
14. The epigenetic modifier ubiquitin-specific protease 22 (USP22) regulates embryonic stem cell differentiation via transcriptional repression of sex-determining region Y-box 2 (SOX2).
- Author
-
Sussman RT, Stanek TJ, Esteso P, Gearhart JD, Knudsen KE, and McMahon SB
- Subjects
- Animals, Cell Line, Cell Proliferation, Endopeptidases genetics, Gene Expression Profiling, Gene Expression Regulation, Developmental, Genetic Loci genetics, Histones metabolism, Mice, Phenotype, Pluripotent Stem Cells metabolism, Protein Binding genetics, RNA, Messenger genetics, RNA, Messenger metabolism, SOXB1 Transcription Factors metabolism, Sirtuin 1 metabolism, Ubiquitin Thiolesterase, Ubiquitin-Specific Proteases genetics, Ubiquitination genetics, Cell Differentiation genetics, Embryonic Stem Cells cytology, Embryonic Stem Cells metabolism, Endopeptidases metabolism, Epigenesis, Genetic, SOXB1 Transcription Factors genetics, Transcription, Genetic, Ubiquitin-Specific Proteases metabolism
- Abstract
Pluripotent embryonic stem cells (ESCs) undergo self-renewal until stimulated to differentiate along specific lineage pathways. Many of the transcriptional networks that drive reprogramming of a self-renewing ESC to a differentiating cell have been identified. However, fundamental questions remain unanswered about the epigenetic programs that control these changes in gene expression. Here we report that the histone ubiquitin hydrolase ubiquitin-specific protease 22 (USP22) is a critical epigenetic modifier that controls this transition from self-renewal to differentiation. USP22 is induced as ESCs differentiate and is necessary for differentiation into all three germ layers. We further report that USP22 is a transcriptional repressor of the locus encoding the core pluripotency factor sex-determining region Y-box 2 (SOX2) in ESCs, and this repression is required for efficient differentiation. USP22 occupies the Sox2 promoter and hydrolyzes monoubiquitin from ubiquitylated histone H2B and blocks transcription of the Sox2 locus. Our study reveals an epigenetic mechanism that represses the core pluripotency transcriptional network in ESCs, allowing ESCs to transition from a state of self-renewal into lineage-specific differentiation programs.
- Published
- 2013
- Full Text
- View/download PDF
15. Optimization of direct fibroblast reprogramming to cardiomyocytes using calcium activity as a functional measure of success.
- Author
-
Addis RC, Ifkovits JL, Pinto F, Kellam LD, Esteso P, Rentschler S, Christoforou N, Epstein JA, and Gearhart JD
- Subjects
- Animals, Cell Line, Embryo, Mammalian cytology, Embryo, Mammalian metabolism, Fibroblasts cytology, Humans, Mice, Myocardial Contraction genetics, Myocytes, Cardiac chemistry, Transcription Factors genetics, Calcium metabolism, Cell Differentiation, Fibroblasts metabolism, Myocytes, Cardiac metabolism, Transcription Factors biosynthesis
- Abstract
Direct conversion of fibroblasts to induced cardiomyocytes (iCMs) has great potential for regenerative medicine. Recent publications have reported significant progress, but the evaluation of reprogramming has relied upon non-functional measures such as flow cytometry for cardiomyocyte markers or GFP expression driven by a cardiomyocyte-specific promoter. The issue is one of practicality: the most stringent measures - electrophysiology to detect cell excitation and the presence of spontaneously contracting myocytes - are not readily quantifiable in the large numbers of cells screened in reprogramming experiments. However, excitation and contraction are linked by a third functional characteristic of cardiomyocytes: the rhythmic oscillation of intracellular calcium levels. We set out to optimize direct conversion of fibroblasts to iCMs with a quantifiable calcium reporter to rapidly assess functional transdifferentiation. We constructed a reporter system in which the calcium indicator GCaMP is driven by the cardiomyocyte-specific Troponin T promoter. Using calcium activity as our primary outcome measure, we compared several published combinations of transcription factors along with novel combinations in mouse embryonic fibroblasts. The most effective combination consisted of Hand2, Nkx2.5, Gata4, Mef2c, and Tbx5 (HNGMT). This combination is >50-fold more efficient than GMT alone and produces iCMs with cardiomyocyte marker expression, robust calcium oscillation, and spontaneous beating that persist for weeks following inactivation of reprogramming factors. HNGMT is also significantly more effective than previously published factor combinations for the transdifferentiation of adult mouse cardiac fibroblasts to iCMs. Quantification of calcium function is a convenient and effective means for the identification and evaluation of cardiomyocytes generated by direct reprogramming. Using this stringent outcome measure, we conclude that HNGMT produces iCMs more efficiently than previously published methods., (Copyright © 2013 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
16. Genome-wide profiling of pluripotent cells reveals a unique molecular signature of human embryonic germ cells.
- Author
-
Pashai N, Hao H, All A, Gupta S, Chaerkady R, De Los Angeles A, Gearhart JD, and Kerr CL
- Subjects
- Animals, Cell Line, Tumor, Cluster Analysis, Genome, Humans, Mice, Microscopy, Phase-Contrast methods, Models, Genetic, Oligonucleotide Array Sequence Analysis, Principal Component Analysis, Transcription, Genetic, Embryonic Stem Cells cytology, Gene Expression Profiling methods, Genome-Wide Association Study, Germ Cells cytology, Pluripotent Stem Cells cytology
- Abstract
Human embryonic germ cells (EGCs) provide a powerful model for identifying molecules involved in the pluripotent state when compared to their progenitors, primordial germ cells (PGCs), and other pluripotent stem cells. Microarray and Principal Component Analysis (PCA) reveals for the first time that human EGCs possess a transcription profile distinct from PGCs and other pluripotent stem cells. Validation with qRT-PCR confirms that human EGCs and PGCs express many pluripotency-associated genes but with quantifiable differences compared to pluripotent embryonic stem cells (ESCs), induced pluripotent stem cells (IPSCs), and embryonal carcinoma cells (ECCs). Analyses also identified a number of target genes that may be potentially associated with their unique pluripotent states. These include IPO7, MED7, RBM26, HSPD1, and KRAS which were upregulated in EGCs along with other pluripotent stem cells when compared to PGCs. Other potential target genes were also found which may contribute toward a primed ESC-like state. These genes were exclusively up-regulated in ESCs, IPSCs and ECCs including PARP1, CCNE1, CDK6, AURKA, MAD2L1, CCNG1, and CCNB1 which are involved in cell cycle regulation, cellular metabolism and DNA repair and replication. Gene classification analysis also confirmed that the distinguishing feature of EGCs compared to ESCs, ECCs, and IPSCs lies primarily in their genetic contribution to cellular metabolism, cell cycle, and cell adhesion. In contrast, several genes were found upregulated in PGCs which may help distinguish their unipotent state including HBA1, DMRT1, SPANXA1, and EHD2. Together, these findings provide the first glimpse into a unique genomic signature of human germ cells and pluripotent stem cells and provide genes potentially involved in defining different states of germ-line pluripotency.
- Published
- 2012
- Full Text
- View/download PDF
17. Identification of RNA binding motif proteins essential for cardiovascular development.
- Author
-
Maragh S, Miller RA, Bessling SL, McGaughey DM, Wessels MW, de Graaf B, Stone EA, Bertoli-Avella AM, Gearhart JD, Fisher S, and McCallion AS
- Subjects
- Animals, Animals, Genetically Modified, Binding Sites, Cardiovascular System embryology, Embryo, Nonmammalian metabolism, Morphogenesis genetics, RNA metabolism, RNA-Binding Proteins metabolism, Zebrafish Proteins metabolism, Gene Expression Regulation, Developmental, RNA-Binding Proteins genetics, Zebrafish embryology, Zebrafish genetics, Zebrafish Proteins genetics
- Abstract
Background: We recently identified Rbm24 as a novel gene expressed during mouse cardiac development. Due to its tightly restricted and persistent expression from formation of the cardiac crescent onwards and later in forming vasculature we posited it to be a key player in cardiogenesis with additional roles in vasculogenesis and angiogenesis., Results: To determine the role of this gene in cardiac development, we have identified its zebrafish orthologs (rbm24a and rbm24b), and functionally evaluated them during zebrafish embryogenesis. Consistent with our underlying hypothesis, reduction in expression of either ortholog through injection of morpholino antisense oligonucleotides results in cardiogenic defects including cardiac looping and reduced circulation, leading to increasing pericardial edema over time. Additionally, morphant embryos for either ortholog display incompletely overlapping defects in the forming vasculature of the dorsal aorta (DA), posterior caudal vein (PCV) and caudal vein (CV) which are the first blood vessels to form in the embryo. Vasculogenesis and early angiogenesis in the trunk were similarly compromised in rbm24 morphant embryos at 48 hours post fertilization (hpf). Subsequent vascular maintenance was impaired in both rbm24 morphants with substantial vessel degradation noted at 72 hpf., Conclusion: Taken collectively, our functional data support the hypothesis that rbm24a and rbm24b are key developmental cardiac genes with unequal roles in cardiovascular formation.
- Published
- 2011
- Full Text
- View/download PDF
18. Quantitative temporal proteomic analysis of human embryonic stem cell differentiation into oligodendrocyte progenitor cells.
- Author
-
Chaerkady R, Letzen B, Renuse S, Sahasrabuddhe NA, Kumar P, All AH, Thakor NV, Delanghe B, Gearhart JD, Pandey A, and Kerr CL
- Subjects
- Animals, Cell Lineage, Gas Chromatography-Mass Spectrometry, Humans, Immunohistochemistry, Mice, Time, Cell Differentiation, Embryonic Stem Cells cytology, Embryonic Stem Cells metabolism, Oligodendroglia cytology, Proteomics, Stem Cells cytology
- Abstract
Oligodendrocytes (OLs) are glial cells of the central nervous system, which produce myelin. Cultured OLs provide immense therapeutic opportunities for treating a variety of neurological conditions. One of the most promising sources for such therapies is human embryonic stem cells (ESCs) as well as providing a model to study human OL development. For these purposes, an investigation of proteome level changes is critical for understanding the process of OL differentiation. In this report, an iTRAQ-based quantitative proteomic approach was used to study multiple steps during OL differentiation including neural progenitor cells, glial progenitor cells and oligodendrocyte progenitor cells (OPCs) compared to undifferentiated ESCs. Using a 1% false discovery rate cutoff, ∼3145 proteins were quantitated and several demonstrated progressive stage-specific expression. Proteins such as transferrin, neural cell adhesion molecule 1, apolipoprotein E and wingless-related MMTV integration site 5A showed increased expression from the neural progenitor cell to the OPC stage. Several proteins that have demonstrated evidence or been suspected in OL maturation were also found upregulated in OPCs including fatty acid-binding protein 4, THBS1, bone morphogenetic protein 1, CRYAB, transferrin, tenascin C, COL3A1, TGFBI and EPB41L3. Thus, by providing the first extensive proteomic profiling of human ESC differentiation into OPCs, this study provides many novel proteins that are potentially involved in OL development., (Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.)
- Published
- 2011
- Full Text
- View/download PDF
19. Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry.
- Author
-
Radoshitzky SR, Warfield KL, Chi X, Dong L, Kota K, Bradfute SB, Gearhart JD, Retterer C, Kranzusch PJ, Misasi JN, Hogenbirk MA, Wahl-Jensen V, Volchkov VE, Cunningham JM, Jahrling PB, Aman MJ, Bavari S, Farzan M, and Kuhn JH
- Subjects
- Animals, Biological Products metabolism, Cell Line, Ebolavirus physiology, Humans, Immunoglobulin Fc Fragments genetics, Marburgvirus physiology, Recombinant Fusion Proteins genetics, Recombinant Fusion Proteins metabolism, Viral Proteins genetics, Antiviral Agents metabolism, Ebolavirus drug effects, Immunoglobulin Fc Fragments metabolism, Marburgvirus drug effects, Viral Proteins metabolism, Virus Internalization drug effects
- Abstract
With the exception of Reston and Lloviu viruses, filoviruses (marburgviruses, ebolaviruses, and "cuevaviruses") cause severe viral hemorrhagic fevers in humans. Filoviruses use a class I fusion protein, GP(1,2), to bind to an unknown, but shared, cell surface receptor to initiate virus-cell fusion. In addition to GP(1,2), ebolaviruses and cuevaviruses, but not marburgviruses, express two secreted glycoproteins, soluble GP (sGP) and small soluble GP (ssGP). All three glycoproteins have identical N termini that include the receptor-binding region (RBR) but differ in their C termini. We evaluated the effect of the secreted ebolavirus glycoproteins on marburgvirus and ebolavirus cell entry, using Fc-tagged recombinant proteins. Neither sGP-Fc nor ssGP-Fc bound to filovirus-permissive cells or inhibited GP(1,2)-mediated cell entry of pseudotyped retroviruses. Surprisingly, several Fc-tagged Δ-peptides, which are small C-terminal cleavage products of sGP secreted by ebolavirus-infected cells, inhibited entry of retroviruses pseudotyped with Marburg virus GP(1,2), as well as Marburg virus and Ebola virus infection in a dose-dependent manner and at low molarity despite absence of sequence similarity to filovirus RBRs. Fc-tagged Δ-peptides from three ebolaviruses (Ebola virus, Sudan virus, and Taï Forest virus) inhibited GP(1,2)-mediated entry and infection of viruses comparably to or better than the Fc-tagged RBRs, whereas the Δ-peptide-Fc of an ebolavirus nonpathogenic for humans (Reston virus) and that of an ebolavirus with lower lethality for humans (Bundibugyo virus) had little effect. These data indicate that Δ-peptides are functional components of ebolavirus proteomes. They join cathepsins and integrins as novel modulators of filovirus cell entry, might play important roles in pathogenesis, and could be exploited for the synthesis of powerful new antivirals.
- Published
- 2011
- Full Text
- View/download PDF
20. IMAGING REDOX STATE HETEROGENEITY WITHIN INDIVIDUAL EMBRYONIC STEM CELL COLONIES.
- Author
-
Xu HN, Addis RC, Goings DF, Nioka S, Chance B, Gearhart JD, and Li LZ
- Abstract
Redox state mediates embryonic stem cell (ESC) differentiation and thus offers an important complementary approach to understanding the pluripotency of stem cells. NADH redox ratio (NADH/(Fp + NADH)), where NADH is the reduced form of nicotinamide adenine dinucleotide and Fp is the oxidized flavoproteins, has been established as a sensitive indicator of mitochondrial redox state. In this paper, we report our redox imaging data on the mitochondrial redox state of mouse ESC (mESC) colonies and the implications thereof. The low-temperature NADH/Fp redox scanner was employed to image mESC colonies grown on a feeder layer of gamma-irradiated mouse embryonic fibroblasts (MEFs) on glass cover slips. The result showed significant heterogeneity in the mitochondrial redox state within individual mESC colonies (size: ∼200-440 μ m), exhibiting a core with a more reduced state than the periphery. This more reduced state positively correlates with the expression pattern of Oct4, a well-established marker of pluripotency. Our observation is the first to show the heterogeneity in the mitochondrial redox state within a mESC colony, suggesting that mitochondrial redox state should be further investigated as a potential new biomarker for the stemness of embryonic stem cells.
- Published
- 2011
- Full Text
- View/download PDF
21. The use of human embryonic stem cells in drug discovery. Counterpoint.
- Author
-
Esteso P and Gearhart JD
- Subjects
- Drug Discovery methods, Drug Evaluation, Preclinical methods, Drug Evaluation, Preclinical trends, Embryonic Stem Cells transplantation, Humans, Induced Pluripotent Stem Cells cytology, Induced Pluripotent Stem Cells transplantation, Drug Discovery trends, Embryonic Stem Cells cytology
- Published
- 2011
- Full Text
- View/download PDF
22. Bone morphogenetic protein 4 mediates human embryonic germ cell derivation.
- Author
-
Hiller M, Liu C, Blumenthal PD, Gearhart JD, and Kerr CL
- Subjects
- Antigens, Differentiation genetics, Antigens, Differentiation metabolism, Bone Morphogenetic Protein 4 physiology, Bone Morphogenetic Protein Receptors genetics, Bone Morphogenetic Protein Receptors metabolism, Cell Differentiation drug effects, Cell Proliferation drug effects, Embryoid Bodies drug effects, Female, Gene Expression Profiling, Germ Cells drug effects, Gestational Age, Humans, Pluripotent Stem Cells drug effects, Pregnancy, Smad Proteins genetics, Smad Proteins metabolism, Up-Regulation, Bone Morphogenetic Protein 4 pharmacology, Germ Cells cytology, Pluripotent Stem Cells cytology, Recombinant Proteins pharmacology
- Abstract
Human primordial germ cells (PGCs) have proven to be a source of pluripotent stem cells called embryonic germ cells (EGCs). Unlike embryonic stem cells, virtually little is known regarding the factors that regulate EGC survival and maintenance. In mice, the growth factor bone morphogenetic protein 4 (BMP4) has been shown to be required for maintaining mouse embryonic stem cells, and disruptions in this gene lead to defects in mouse PGC specification. Here, we sought to determine whether recombinant human BMP4 could influence EGC derivation and/or human PGC survival. We found that the addition of recombinant BMP4 increased the number of human PGCs after 1 week of culture in a dose-responsive manner. The efficiency of EGC derivation and maintenance in culture was also enhanced by the presence of recombinant BMP4 based on alkaline phosphatase and OCT4 staining. In addition, an antagonist of the BMP4 pathway, Noggin, decreased PGC proliferation and led to an increase in cystic embryoid body formation. Quantitative real-time (qRT)-polymerase chain reaction analyses and immunostaining confirmed that the constituents of the BMP4 pathway were upregulated in EGCs versus PGCs. Downstream activators of the BMP4 pathway such as ID1 and phosphorylated SMADs 1 and 5 were also expressed, suggesting a role of this growth factor in EGC pluripotency.
- Published
- 2011
- Full Text
- View/download PDF
23. Efficient conversion of astrocytes to functional midbrain dopaminergic neurons using a single polycistronic vector.
- Author
-
Addis RC, Hsu FC, Wright RL, Dichter MA, Coulter DA, and Gearhart JD
- Subjects
- Animals, DNA, Complementary genetics, Electrophysiological Phenomena, Fibroblasts cytology, Fibroblasts metabolism, Gene Expression Profiling, Gene Expression Regulation, Humans, Immunohistochemistry, Mesencephalon metabolism, Mice, Open Reading Frames genetics, Transcription Factors metabolism, Transcription, Genetic, Astrocytes cytology, Astrocytes metabolism, Dopaminergic Neurons cytology, Dopaminergic Neurons metabolism, Genes genetics, Genetic Vectors genetics, Mesencephalon cytology
- Abstract
Direct cellular reprogramming is a powerful new tool for regenerative medicine. In efforts to understand and treat Parkinson's Disease (PD), which is marked by the degeneration of dopaminergic neurons in the midbrain, direct reprogramming provides a valuable new source of these cells. Astrocytes, the most plentiful cells in the central nervous system, are an ideal starting population for the direct generation of dopaminergic neurons. In addition to their potential utility in cell replacement therapies for PD or in modeling the disease in vitro, astrocyte-derived dopaminergic neurons offer the prospect of direct in vivo reprogramming within the brain. As a first step toward this goal, we report the reprogramming of astrocytes to dopaminergic neurons using three transcription factors - ASCL1, LMX1B, and NURR1 - delivered in a single polycistronic lentiviral vector. The process is efficient, with 18.2±1.5% of cells expressing markers of dopaminergic neurons after two weeks. The neurons exhibit expression profiles and electrophysiological characteristics consistent with midbrain dopaminergic neurons, notably including spontaneous pacemaking activity, stimulated release of dopamine, and calcium oscillations. The present study is the first demonstration that a single vector can mediate reprogramming to dopaminergic neurons, and indicates that astrocytes are an ideal starting population for the direct generation of dopaminergic neurons.
- Published
- 2011
- Full Text
- View/download PDF
24. Influence of Electromechanical Activity on Cardiac Differentiation of Mouse Embryonic Stem Cells.
- Author
-
Limpitikul W, Christoforou N, Thompson SA, Gearhart JD, Tung L, and Lipke EA
- Abstract
During differentiation, mouse embryonic stem cell-derived cardiomyocytes (mESC-CMs) receive electromechanical cues from spontaneous beating. Therefore, promoting electromechanical activity via electrical pacing or suppressing it by drug treatment might affect the cellular functional development. Electrical pacing was applied to confluent monolayers of mESC-CMs during late-stage differentiation (days 16-18). Alternatively, spontaneous contraction was suppressed by (a) blocking ion currents with CsCl (HCN channel), trazodone (T-type Ca
2+ channel), or both CsCl and trazodone on days 11-18; or (b) applying blebbistatin (excitation-contraction uncoupler) on days 11-14. Electrophysiological properties and gene expression were examined on day 19 and 18, respectively. Optical mapping revealed no significant difference in conduction velocity (CV)in paced vs. non-pacedmonolayers, nor were there significant changes in gene expression of connexin-43, Na-Ca exchanger (NCX), or myosin heavy chain (MHC). However, CV variability among differentiation batches and CV heterogeneity within individual monolayers were significantly lower in paced mESC-CMs. Alternatively, while the four drug treatments suppressed contraction with varying degrees (up to complete inhibition), there was no significant difference in CV for any of the treatments compared with controls. Trazodone treatment significantly reduced CV variability as compared to controls, whereas CsCl treatment significantly reduced CV heterogeneity. Distinct changes in gene expression of connexin-43, MHC, HCNl, Cav3.1/3.2 were not observed. Electrical pacing, but not suppression of spontaneous contraction, during late-stage differentiation reduces the intrinsic variability of CV among differentiation batches and across individual monolayers, which can be beneficial in the application of ESCs for myocardial tissue repair.- Published
- 2010
- Full Text
- View/download PDF
25. Implantation of mouse embryonic stem cell-derived cardiac progenitor cells preserves function of infarcted murine hearts.
- Author
-
Christoforou N, Oskouei BN, Esteso P, Hill CM, Zimmet JM, Bian W, Bursac N, Leong KW, Hare JM, and Gearhart JD
- Subjects
- Animals, Cell Differentiation, Cell Line, Cells, Cultured, Disease Models, Animal, Echocardiography, Female, Kaplan-Meier Estimate, Mice, Myocardial Infarction mortality, Myocytes, Cardiac cytology, Reverse Transcriptase Polymerase Chain Reaction, Stem Cell Transplantation methods, Embryonic Stem Cells transplantation, Myocardial Infarction therapy, Myocytes, Cardiac transplantation
- Abstract
Stem cell transplantation holds great promise for the treatment of myocardial infarction injury. We recently described the embryonic stem cell-derived cardiac progenitor cells (CPCs) capable of differentiating into cardiomyocytes, vascular endothelium, and smooth muscle. In this study, we hypothesized that transplanted CPCs will preserve function of the infarcted heart by participating in both muscle replacement and neovascularization. Differentiated CPCs formed functional electromechanical junctions with cardiomyocytes in vitro and conducted action potentials over cm-scale distances. When transplanted into infarcted mouse hearts, CPCs engrafted long-term in the infarct zone and surrounding myocardium without causing teratomas or arrhythmias. The grafted cells differentiated into cross-striated cardiomyocytes forming gap junctions with the host cells, while also contributing to neovascularization. Serial echocardiography and pressure-volume catheterization demonstrated attenuated ventricular dilatation and preserved left ventricular fractional shortening, systolic and diastolic function. Our results demonstrate that CPCs can engraft, differentiate, and preserve the functional output of the infarcted heart.
- Published
- 2010
- Full Text
- View/download PDF
26. MicroRNA expression profiling of oligodendrocyte differentiation from human embryonic stem cells.
- Author
-
Letzen BS, Liu C, Thakor NV, Gearhart JD, All AH, and Kerr CL
- Subjects
- Biomarkers metabolism, Cell Differentiation genetics, Cell Line, Cell Lineage genetics, Cluster Analysis, Embryonic Stem Cells metabolism, Fluorescent Antibody Technique, Gene Expression Regulation, Developmental, Humans, MicroRNAs metabolism, Myelin Sheath genetics, Principal Component Analysis, Reproducibility of Results, Embryonic Stem Cells cytology, Gene Expression Profiling, MicroRNAs genetics, Oligodendroglia cytology, Oligodendroglia metabolism
- Abstract
Background: Cells of the oligodendrocyte (OL) lineage play a vital role in the production and maintenance of myelin, a multilamellar membrane which allows for saltatory conduction along axons. These cells may provide immense therapeutic potential for lost sensory and motor function in demyelinating conditions, such as spinal cord injury, multiple sclerosis, and transverse myelitis. However, the molecular mechanisms controlling OL differentiation are largely unknown. MicroRNAs (miRNAs) are considered the "micromanagers" of gene expression with suggestive roles in cellular differentiation and maintenance. Although unique patterns of miRNA expression in various cell lineages have been characterized, this is the first report documenting their expression during oligodendrocyte maturation from human embryonic stem (hES) cells. Here, we performed a global miRNA analysis to reveal and identify characteristic patterns in the multiple stages leading to OL maturation from hES cells including those targeting factors involved in myelin production., Methodology/principal Findings: We isolated cells from 8 stages of OL differentiation. Total RNA was subjected to miRNA profiling and validations preformed using real-time qRT-PCR. A comparison of miRNAs from our cultured OLs and OL progenitors showed significant similarities with published results from equivalent cells found in the rat and mouse central nervous system. Principal component analysis revealed four main clusters of miRNA expression corresponding to early, mid, and late progenitors, and mature OLs. These results were supported by correlation analyses between adjacent stages. Interestingly, the highest differentially-expressed miRNAs demonstrated a similar pattern of expression throughout all stages of differentiation, suggesting that they potentially regulate a common target or set of targets in this process. The predicted targets of these miRNAs include those with known or suspected roles in oligodendrocyte development and myelination including C11Orf9, CLDN11, MYTL1, MBOP, MPZL2, and DDR1., Conclusions/significance: We demonstrate miRNA profiles during distinct stages in oligodendroglial differentiation that may provide key markers of OL maturation. Our results reveal pronounced trends in miRNA expression and their potential mRNA target interactions that could provide valuable insight into the molecular mechanisms of differentiation.
- Published
- 2010
- Full Text
- View/download PDF
27. Comparative proteomics of human embryonic stem cells and embryonal carcinoma cells.
- Author
-
Chaerkady R, Kerr CL, Kandasamy K, Marimuthu A, Gearhart JD, and Pandey A
- Subjects
- Chromatography, Liquid, Humans, Immunohistochemistry, Isotope Labeling, Microscopy, Fluorescence, Peptide Fragments metabolism, Proteome metabolism, Reproducibility of Results, Tandem Mass Spectrometry, Embryonal Carcinoma Stem Cells metabolism, Embryonic Stem Cells metabolism, Proteomics methods
- Abstract
Pluripotent human embryonic stem cells (ESCs) can be differentiated in vitro into a variety of cells which hold promise for transplantation therapy. Human embryonal carcinoma cells (ECCs), stem cells of human teratocarcinomas, are considered a close but malignant counterpart to human ESCs. In this study, a comprehensive quantitative proteomic analysis of ESCs and ECCs was carried out using the iTRAQ method. Using two-dimensional LC and MS/MS analyses, we identified and quantitated approximately 1800 proteins. Among these are proteins associated with pluripotency and development as well as tight junction signaling and TGFbeta receptor pathway. Nearly approximately 200 proteins exhibit more than twofold difference in abundance between ESCs and ECCs. Examples of early developmental markers high in ESCs include beta-galactoside-binding lectin, undifferentiated embryonic cell transcription factor-1, DNA cytosine methyltransferase 3beta isoform-B, melanoma antigen family-A4, and interferon-induced transmembrane protein-1. In contrast, CD99-antigen (CD99), growth differentiation factor-3, cellular retinoic acid binding protein-2, and developmental pluripotency associated-4 were among the highly expressed proteins in ECCs. Several proteins that were highly expressed in ECCs such as heat shock 27 kDa protein-1, mitogen-activated protein kinase kinase-1, nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor like-2, and S100 calcium-binding protein-A4 have also been attributed to malignancy in other systems. Importantly, immunocytochemistry was used to validate the proteomic analyses for a subset of the proteins. In summary, this is the first large-scale quantitative proteomic study of human ESCs and ECCs, which provides critical information about the regulators of these two closely related, but developmentally distinct, stem cells.
- Published
- 2010
- Full Text
- View/download PDF
28. Efficient differentiation of human embryonic stem cells into oligodendrocyte progenitors for application in a rat contusion model of spinal cord injury.
- Author
-
Kerr CL, Letzen BS, Hill CM, Agrawal G, Thakor NV, Sterneckert JL, Gearhart JD, and All AH
- Subjects
- Animals, Antigens metabolism, Disease Models, Animal, Evoked Potentials, Somatosensory physiology, Female, Gangliosides metabolism, Humans, Nerve Tissue Proteins metabolism, O Antigens metabolism, Proteoglycans metabolism, Rats, Receptor, Platelet-Derived Growth Factor alpha metabolism, SOXE Transcription Factors metabolism, Spinal Cord Injuries physiopathology, Stem Cell Transplantation methods, Cell Differentiation physiology, Embryonic Stem Cells physiology, Oligodendroglia physiology, Spinal Cord Injuries surgery
- Abstract
This study utilized a contusion model of spinal cord injury (SCI) in rats using the standardized NYU-MASCIS impactor, after which oligodendrocyte progenitor cells (OPCs) derived from human embryonic stem cell (ESC) were transplanted into the spinal cord to study their survival and migration route toward the areas of injury. One critical aspect of successful cell-based SCI therapy is the time of injection following injury. OPCs were injected at two clinically relevant times when most damage occurs to the surrounding tissue, 3 and 24 hours following injury. Migration and survivability after eight days was measured postmortem. In-vitro immunofluorescence revealed that most ESC-derived OPCs expressed oligodendrocyte markers, including CNPase, GalC, Olig1, O4, and O1. Results showed that OPCs survived when injected at the center of injury and migrated away from the injection sites after one week. Histological sections revealed integration of ESC-derived OPCs into the spinal cord with contusion injury without disruption to the parenchyma. Cells survived for a minimum of eight days after injury, without tumor or cyst formation. The extent of injury and effect of early cell transplant was measured using behavioral and electrophysiological assessments which demonstrated increased neurological responses in rats transplanted with OPCs compared to controls.
- Published
- 2010
- Full Text
- View/download PDF
29. Unintended changes in cognition, mood, and behavior arising from cell-based interventions for neurological conditions: ethical challenges.
- Author
-
Duggan PS, Siegel AW, Blass DM, Bok H, Coyle JT, Faden R, Finkel J, Gearhart JD, Greely HT, Hillis A, Hoke A, Johnson R, Johnston M, Kahn J, Kerr D, King P, Kurtzberg J, Liao SM, McDonald JW, McKhann G, Nelson KB, Rao M, Regenberg A, Smith K, Solter D, Song H, Sugarman J, Traystman RJ, Vescovi A, Yanofski J, Young W, and Mathews DJ
- Subjects
- Biomedical Research ethics, Brain Tissue Transplantation adverse effects, Cell Transplantation adverse effects, Ethics, Research, Humans, Neuropsychological Tests, Research Subjects, Surveys and Questionnaires, Therapeutic Human Experimentation ethics, Affect, Behavior, Brain Tissue Transplantation ethics, Cell Transplantation ethics, Central Nervous System Diseases surgery, Clinical Trials as Topic ethics, Cognition, Informed Consent
- Abstract
The prospect of using cell-based interventions (CBIs) to treat neurological conditions raises several important ethical and policy questions. In this target article, we focus on issues related to the unique constellation of traits that characterize CBIs targeted at the central nervous system. In particular, there is at least a theoretical prospect that these cells will alter the recipients' cognition, mood, and behavior-brain functions that are central to our concept of the self. The potential for such changes, although perhaps remote, is cause for concern and careful ethical analysis. Both to enable better informed consent in the future and as an end in itself, we argue that early human trials of CBIs for neurological conditions must monitor subjects for changes in cognition, mood, and behavior; further, we recommend concrete steps for that monitoring. Such steps will help better characterize the potential risks and benefits of CBIs as they are tested and potentially used for treatment.
- Published
- 2009
- Full Text
- View/download PDF
30. Temporal analysis of neural differentiation using quantitative proteomics.
- Author
-
Chaerkady R, Kerr CL, Marimuthu A, Kelkar DS, Kashyap MK, Gucek M, Gearhart JD, and Pandey A
- Subjects
- Cells, Cultured, Embryonic Stem Cells physiology, Humans, Proteome metabolism, Antigens, Differentiation metabolism, Cell Differentiation physiology, Embryonic Stem Cells cytology, Neurogenesis physiology
- Abstract
The ability to derive neural progenitors, differentiated neurons and glial cells from human embryonic stem cells (hESCs) with high efficiency holds promise for a number of clinical applications. However, investigating the temporal events is crucial for defining the underlying mechanisms that drive this process of differentiation along different lineages. We carried out quantitative proteomic profiling using a multiplexed approach capable of analyzing eight different samples simultaneously to monitor the temporal dynamics of protein abundance as human embryonic stem cells differentiate into motor neurons or astrocytes. With this approach, a catalog of approximately 1200 proteins along with their relative quantitative expression patterns was generated. The differential expression of the large majority of these proteins has not previously been reported or studied in the context of neural differentiation. As expected, two of the widely used markers of pluripotency, alkaline phosphatase (ALPL) and LIN28, were found to be downregulated during differentiation, while S-100 and tenascin C were upregulated in astrocytes. Neurofilament 3 protein, doublecortin and CAM kinase-like 1 and nestin proteins were upregulated during motor neuron differentiation. We identified a number of proteins whose expression was largely confined to specific cell types, embryonic stem cells, embryoid bodies and differentiating motor neurons. For example, glycogen phosphorylase (PYGL) and fatty acid binding protein 5 (FABP5) were enriched in ESCs, while beta spectrin (SPTBN5) was highly expressed in embryoid bodies. Karyopherin, heat shock 27 kDa protein 1 and cellular retinoic acid binding protein 2 (CRABP2) were upregulated in differentiating motor neurons but were downregulated in mature motor neurons. We validated some of the novel markers of the differentiation process using immunoblotting and immunocytochemical labeling. To our knowledge, this is the first large-scale temporal proteomic profiling of human stem cell differentiation into neural cell types highlighting proteins with limited or undefined roles in neural fate.
- Published
- 2009
- Full Text
- View/download PDF
31. The use of animals in human stem cell research: past, present, and future.
- Author
-
Gearhart JD and Addis RC
- Subjects
- Animals, Humans, Regenerative Medicine methods, Stem Cell Transplantation methods, Regenerative Medicine trends, Stem Cell Transplantation trends, Stem Cells cytology
- Published
- 2009
- Full Text
- View/download PDF
32. The role of animal models in evaluating reasonable safety and efficacy for human trials of cell-based interventions for neurologic conditions.
- Author
-
Regenberg A, Mathews DJ, Blass DM, Bok H, Coyle JT, Duggan P, Faden R, Finkel J, Gearhart JD, Hillis A, Hoke A, Johnson R, Johnston M, Kahn J, Kerr D, King P, Kurtzberg J, Liao SM, McDonald JW, McKhann G, Nelson KB, Rao M, Siegel AW, Smith K, Solter D, Song H, Sugarman J, Vescovi A, Young W, Greely HT, and Traystman RJ
- Subjects
- Animals, Clinical Trials as Topic, Humans, Models, Animal, Risk Factors, Models, Neurological, Safety Management
- Abstract
Progress in regenerative medicine seems likely to produce new treatments for neurologic conditions that use human cells as therapeutic agents; at least one trial for such an intervention is already under way. The development of cell-based interventions for neurologic conditions (CBI-NCs) will likely include preclinical studies using animals as models for humans with conditions of interest. This paper explores predictive validity challenges and the proper role for animal models in developing CBI-NCs. In spite of limitations, animal models are and will remain an essential tool for gathering data in advance of first-in-human clinical trials. The goal of this paper is to provide a realistic lens for viewing the role of animal models in the context of CBI-NCs and to provide recommendations for moving forward through this challenging terrain.
- Published
- 2009
- Full Text
- View/download PDF
33. SOX17 directly activates Zfp202 transcription during in vitro endoderm differentiation.
- Author
-
Patterson ES, Addis RC, Shamblott MJ, and Gearhart JD
- Subjects
- Animals, Cell Line, Tumor, Chromatin Immunoprecipitation, Clone Cells, Cloning, Molecular, Electrophoretic Mobility Shift Assay, Embryonic Development genetics, Gene Expression Regulation, Developmental, Hepatocyte Nuclear Factor 4 genetics, Humans, Mice, Promoter Regions, Genetic genetics, Protein Binding, Repressor Proteins metabolism, SOXF Transcription Factors genetics, Cell Differentiation, Endoderm cytology, Repressor Proteins genetics, SOXF Transcription Factors metabolism, Transcription, Genetic
- Abstract
SOX17 is a SRY-related high-mobility group (HMG) box transcription factor that is necessary for endoderm formation in multiple species. Despite its essential function during endoderm formation and differentiation, few direct targets of SOX17 are known. To identify targets of SOX17, we isolated SOX17 binding sites with a chromatin immunoprecipitation (ChIP)-cloning screen. SOX17-ChIP identified zinc finger protein 202 (Zfp202) as a direct target of SOX17 during endoderm differentiation of F9 embryonal carcinoma cells. A sequence in the first intron of Zfp202 activated transcription in differentiated F9 cells, and overexpression of Sox17 increased the transcriptional activity of this sequence. SOX17 binds to a site within this sequence in electrophoretic mobility shift assays, and mutation of this site decreases the transcriptional activation. Zfp202 is induced concomitantly with Sox17 during endoderm differentiation of F9 cells. We also show that ZFP202 represses Hnf4a, which has been reported for the human ortholog ZNF202. Identifying targets of SOX17 will help to elucidate the molecular basis of endoderm differentiation and may provide a better understanding of the role of endoderm in patterning the other germ layers.
- Published
- 2008
- Full Text
- View/download PDF
34. Comment on "Magnetic resonance spectroscopy identifies neural progenitor cells in the live human brain".
- Author
-
Jansen JF, Gearhart JD, and Bulte JW
- Subjects
- Algorithms, Animals, Embryonic Stem Cells chemistry, Embryonic Stem Cells cytology, Humans, Mice, Neurons chemistry, Stem Cells chemistry, Biomarkers analysis, Brain cytology, Lipids analysis, Magnetic Resonance Spectroscopy methods, Neurons cytology, Stem Cells cytology
- Abstract
Manganas et al. (Reports, 9 November 2007, p. 980) reported the discovery of a biomarker specific for neural progenitor cells detectable using magnetic resonance spectroscopy. A new algorithm was developed to extract the biomarker from noisy in vivo data. We question how this algorithm was validated, because the biomarker overlaps with peaks from nonspecific lipid signals.
- Published
- 2008
- Full Text
- View/download PDF
35. Cell-based interventions for neurologic conditions: ethical challenges for early human trials.
- Author
-
Mathews DJ, Sugarman J, Bok H, Blass DM, Coyle JT, Duggan P, Finkel J, Greely HT, Hillis A, Hoke A, Johnson R, Johnston M, Kahn J, Kerr D, Kurtzberg J, Liao SM, McDonald JW, McKhann G, Nelson KB, Rao M, Regenberg A, Siegel AW, Smith K, Solter D, Song H, Vescovi A, Young W, Gearhart JD, and Faden R
- Subjects
- Animals, Biomedical Research ethics, Biomedical Research standards, Biomedical Research trends, Cell- and Tissue-Based Therapy methods, Cell- and Tissue-Based Therapy standards, Clinical Trials Data Monitoring Committees standards, Clinical Trials Data Monitoring Committees trends, Clinical Trials as Topic standards, Ethics Committees, Research standards, Ethics Committees, Research trends, Humans, Neurology trends, Risk Assessment, Stem Cell Transplantation ethics, Stem Cell Transplantation methods, Stem Cell Transplantation standards, Time Factors, United States, United States Food and Drug Administration standards, United States Food and Drug Administration trends, Brain Diseases therapy, Cell- and Tissue-Based Therapy ethics, Clinical Trials as Topic ethics, Neurology ethics, Neurology standards
- Abstract
Background: Attempts to translate basic stem cell research into treatments for neurologic diseases and injury are well under way. With a clinical trial for one such treatment approved and in progress in the United States, and additional proposals under review, we must begin to address the ethical issues raised by such early forays into human clinical trials for cell-based interventions for neurologic conditions., Methods: An interdisciplinary working group composed of experts in neuroscience, cell biology, bioethics, law, and transplantation, along with leading disease researchers, was convened twice over 2 years to identify and deliberate on the scientific and ethical issues raised by the transition from preclinical to clinical research of cell-based interventions for neurologic conditions., Results: While the relevant ethical issues are in many respects standard challenges of human subjects research, they are heightened in complexity by the novelty of the science, the focus on the CNS, and the political climate in which the science is proceeding., Conclusions: Distinctive challenges confronting US scientists, administrators, institutional review boards, stem cell research oversight committees, and others who will need to make decisions about work involving stem cells and their derivatives and evaluate the ethics of early human trials include evaluating the risks, safety, and benefits of these trials, determining and evaluating cell line provenance, and determining inclusion criteria, informed consent, and the ethics of conducting early human trials in the public spotlight. Further study and deliberation by stakeholders is required to move toward professional and institutional policies and practices governing this research.
- Published
- 2008
- Full Text
- View/download PDF
36. Efficient array-based identification of novel cardiac genes through differentiation of mouse ESCs.
- Author
-
Miller RA, Christoforou N, Pevsner J, McCallion AS, and Gearhart JD
- Subjects
- Animals, Cell Separation, In Situ Hybridization, Mice, Oligonucleotide Array Sequence Analysis, Reverse Transcriptase Polymerase Chain Reaction, Cell Differentiation, Embryonic Stem Cells cytology, Gene Expression Profiling, Myocardium metabolism
- Abstract
Remarkably, although cardiac disease accounts for the largest proportion of adult mortality and morbidity in the industrialized world, the genetic programs controlling early cardiogenesis are largely incompletely understood. To better understand this process, we set out to identify genes whose expression is enriched within early cardiac fated populations, obtaining the transcriptional signatures of mouse embryonic stem cells (mESCs) at defined intervals during their differentiation along a cardiac path. We compared the RNA profiles of cardiac precursors cells (CPCs) with time-matched non-CPCs and undifferentiated mESCs, using a transgenic mESC line harboring an Nkx2-5 cardiac-specific regulatory sequence driving green fluorescent protein (GFP) to facilitate selection of CPCs. We identify 176 transcripts that are significantly elevated in their abundance within CPCs compared with other assayed populations, predicting that they will likely play a role in cardiogenesis. Of note, approximately 24% (43/176) of the cardiogenic candidate transcripts have known roles in cardiac function or development. Importantly, we evaluated the biological relevance of a significant subset 31/133 (23%) of the remaining candidate genes by in situ hybridization at multiple time points during development (embryonic day, E7.5-9.5) and report that all were expressed in key cardiac structures during cardiogenesis. Furthermore 9/31, of which many were previously uncharacterized, were detected as early as the formation of the cardiac crescent. These data demonstrate the potential power of integrating genomic approaches with mESC differentiation to illuminate developmental processes, and provides a valuable resource that may be mined to further elucidate the genetic programs underlying cardiogenesis.
- Published
- 2008
- Full Text
- View/download PDF
37. Expression of pluripotent stem cell markers in the human fetal ovary.
- Author
-
Kerr CL, Hill CM, Blumenthal PD, and Gearhart JD
- Subjects
- Alkaline Phosphatase biosynthesis, Antigens, Surface biosynthesis, Biomarkers metabolism, Female, Fetus cytology, Glycosphingolipids biosynthesis, Humans, In Situ Hybridization, Fluorescence, Lewis X Antigen biosynthesis, Octamer Transcription Factor-3 biosynthesis, Pregnancy, Proteoglycans biosynthesis, Proto-Oncogene Proteins c-kit biosynthesis, Stage-Specific Embryonic Antigens, Ovary cytology, Ovary embryology, Pluripotent Stem Cells metabolism
- Abstract
Background: Human primordial germ cells (PGCs) can give rise to pluripotent stem cells such as embryonal carcinoma cells (ECCs) and embryonic germ cells (EGCs)., Methods: In order to determine whether PGCs express markers associated with pluripotency in EGCs and ECCs, the following study cross examines the expression patterns of multiple pluripotent markers in the human fetal ovary, 5.5-15 weeks post-fertilizaton (pF) and relates this expression with the ability to derive pluripotent EGCs in vitro., Results: Specific subpopulations were identified which included OCT4(+)/Nanog(+)/cKIT(+)/VASA(+) PGCs and oogonia. Interestingly, these cells also expressed SSEA1 and alkaline phosphatase (AP) and SSEA4 expression occurred throughout the entire gonad. Isolation of SSEA1(+) cells from the gonad resulted in AP(+) EGC colony formation. The number of OCT4(+) or Nanog(+) expressing cells peaked by week 8 and then diminished after week 9 pF, as oogonia enter meiosis. In addition, the efficiency of EGC derivation was associated with the number of OCT4(+) cells. TRA-1-60 and TRA-1-81 were only detected in the lining of the mesonephric ducts and occasionally in the gonad., Conclusions: These results demonstrate that PGCs, a unipotent cell, express most, but not all, of the markers associated with pluripotent cells in the human fetal ovary.
- Published
- 2008
- Full Text
- View/download PDF
38. Mouse ES cell-derived cardiac precursor cells are multipotent and facilitate identification of novel cardiac genes.
- Author
-
Christoforou N, Miller RA, Hill CM, Jie CC, McCallion AS, and Gearhart JD
- Subjects
- Animals, Cell Differentiation, Cells, Cultured, In Situ Hybridization, Mice, Oligonucleotide Array Sequence Analysis, Embryonic Stem Cells cytology, Gene Expression Profiling, Multipotent Stem Cells cytology, Myocardium metabolism, Myocytes, Cardiac cytology
- Abstract
Although the differentiation of ES cells to cardiomyocytes has been firmly established, the extent to which corresponding cardiac precursor cells can contribute to other cardiac populations remains unclear. To determine the molecular and cellular characteristics of cardiac-fated populations derived from mouse ES (mES) cells, we isolated cardiac progenitor cells (CPCs) from differentiating mES cell cultures by using a reporter cell line that expresses GFP under the control of a cardiac-specific enhancer element of Nkx2-5, a transcription factor expressed early in cardiac development. This ES cell-derived CPC population initially expressed genetic markers of both stem cells and mesoderm, while differentiated CPCs displayed markers of 3 distinct cell lineages (cardiomyocytes, vascular smooth muscle cells, and endothelial cells)--Flk1 (also known as Kdr), c-Kit, and Nkx2-5, but not Brachyury--and subsequently expressed Isl1. Clonally derived CPCs also demonstrated this multipotent phenotype. By transcription profiling of CPCs, we found that mES cell-derived CPCs displayed a transcriptional signature that paralleled in vivo cardiac development. Additionally, these studies suggested the involvement of genes that we believe were previously unknown to play a role in cardiac development. Taken together, our data demonstrate that ES cell-derived CPCs comprise a multipotent precursor population capable of populating multiple cardiac lineages and suggest that ES cell differentiation is a valid model for studying development of multiple cardiac-fated tissues.
- Published
- 2008
- Full Text
- View/download PDF
39. Expression of pluripotent stem cell markers in the human fetal testis.
- Author
-
Kerr CL, Hill CM, Blumenthal PD, and Gearhart JD
- Subjects
- Biomarkers metabolism, Cell Differentiation, DNA-Binding Proteins metabolism, Fluorescent Antibody Technique, Indirect, Gestational Age, Glycosphingolipids metabolism, Homeodomain Proteins metabolism, Humans, Lewis X Antigen metabolism, Male, Nanog Homeobox Protein, Octamer Transcription Factor-3 metabolism, Proto-Oncogene Proteins c-kit metabolism, Sex Differentiation, Spermatozoa cytology, Spermatozoa metabolism, Stage-Specific Embryonic Antigens, Testis cytology, Testis metabolism, Embryonic Stem Cells cytology, Embryonic Stem Cells metabolism, Pluripotent Stem Cells cytology, Pluripotent Stem Cells metabolism, Testis embryology
- Abstract
Human primordial germ cells (PGCs) have proven to be a source of pluripotent stem cells called embryonic germ cells (EGCs). However, the developmental potency of these cells in the fetal gonad still remains elusive. Thus, this study provides a comprehensive analysis of pluripotent and germ cell marker expression in human fetal testis 7-15 weeks postfertilization (pF) and compares this expression to their ability to derive EGCs. Although the majority of germ cells expressed stem cell markers stage-specific embryonic antigen (SSEA) 1, SSEA4, EMA-1, and alkaline phosphatase, only a small percentage of those (<1%) expressed OCT4, CKIT, and NANOG. Specifically, the number of OCT4(+)/CKIT(+)/NANOG(+) cells significantly increased in the developing cords during weeks 7-9, followed by a gradual decline into week 15 pF. By week 15 pF, the remaining OCT4(+)/CKIT(+)/NANOG(+) cells were found in the cords surrounding the periphery of the testis, and the predominant germ cells, CKIT(+) cells, no longer expressed OCT4 or NANOG. Based on morphology and early germ cell marker expression, including VASA, PUM2, and DAZL, we suggest these cells are mitotically active gonocytes or prespermatogonia. Importantly, the number of OCT4(+) cells correlated with an increase in the number of EGC colonies derived in culture. Interestingly, two pluripotent markers, Tra-1-60 and Tra-1-81, although highly expressed in EGCs, were not expressed by PGCs in the gonad. Together, these results suggest that PGCs maintain expression of pluripotent stem cell markers during and after sexual differentiation of the gonad, albeit in very low numbers.
- Published
- 2008
- Full Text
- View/download PDF
40. Stem cells and their potential in cell-based cardiac therapies.
- Author
-
Christoforou N and Gearhart JD
- Subjects
- Adult Stem Cells physiology, Adult Stem Cells transplantation, Animals, Bone Marrow Cells physiology, Bone Marrow Transplantation, Cell Differentiation, Cell Lineage, Cell Proliferation, Embryonic Stem Cells physiology, Embryonic Stem Cells transplantation, Heart Diseases pathology, Heart Diseases physiopathology, Humans, Mesenchymal Stem Cell Transplantation, Mesenchymal Stem Cells physiology, Myoblasts, Cardiac physiology, Myoblasts, Cardiac transplantation, Myoblasts, Skeletal physiology, Myoblasts, Skeletal transplantation, Myocardial Infarction physiopathology, Myocardial Infarction surgery, Treatment Outcome, Cardiac Surgical Procedures, Heart physiopathology, Heart Diseases surgery, Myocardium pathology, Regeneration, Stem Cell Transplantation, Stem Cells physiology
- Abstract
Stem cells are potential agents for the treatment of myocardial infarcts among other heart diseases. Over the past decade, the scientific community has extensively used a wide variety of cells and examined their capacity to both regenerate the infarcted myocardium and improve functionally the diseased hearts. Some of the cells used include skeletal myoblasts, bone marrow-derived cells, adult cardiac resident stem cells, mesenchymal stem cells, and both mouse and human embryonic stem cells (Nat Biotechnol 2005;23:845-856). The reported cardiogenic capacity of the utilitized stem cells is assayed both in vitro through the use of differentiation paradigms and in vivo through transplantation into a variety of animal models of cardiac disease. The purpose of this review article is to summarize recent stem cell applications in cell-based cardiac therapies and their outcomes.
- Published
- 2007
- Full Text
- View/download PDF
41. Embryonic germ cells: when germ cells become stem cells.
- Author
-
Kerr CL, Gearhart JD, Elliott AM, and Donovan PJ
- Subjects
- Animals, Gene Expression Regulation, Developmental, Germ Cells metabolism, Germ Cells transplantation, Humans, Stem Cells metabolism, Embryo, Mammalian cytology, Germ Cells cytology, Stem Cells cytology
- Abstract
Embryonic germ cells (EGCs) are pluripotent stem cells derived from primordial germ cells (PGCs). PGCs are progenitors of adult gametes, which diverge from the somatic lineage between late embryonic to early fetal development. First derived in the mouse, EGCs have also been derived from human, chicken, and pig. As pluripotent stem cells, EGCs demonstrate long-term self-renewal via clonal expansion in an undifferentiated state, and differentiate in vitro to form embryoid bodies containing cells that represent all three germ layers as well as mixed cell populations of less differentiated progenitors and precursors. This is also demonstrated in vivo by their formation into experimentally induced teratocarcinomas following transplantation. Furthermore, mice, pig, and chicken EGCs have also been shown to contribute to experimentally produced chimeric animals, including germline transmission. Importantly, EGCs demonstrate normal and stable karyotypes as well as normal patterns of genomic imprinting, including X-inactivation. Transplantation studies have begun in a variety of models in hopes of defining their potential use to treat a wide variety of human conditions, including diabetes and urological and neurological disorders.
- Published
- 2006
- Full Text
- View/download PDF
42. Stem cell profiling by nuclear magnetic resonance spectroscopy.
- Author
-
Jansen JF, Shamblott MJ, van Zijl PC, Lehtimäki KK, Bulte JW, Gearhart JD, and Hakumäki JM
- Subjects
- Animals, Cell Line, Mice, Magnetic Resonance Spectroscopy methods, Neurons cytology, Neurons metabolism, Phosphorylcholine analysis, Stem Cells cytology, Stem Cells metabolism
- Abstract
The classification of embryonic and adult stem cells, including their derivatives, is still limited, and often these cells are best defined by their functional properties. Recent gene array studies have yielded contradictory results. Also, very little is known about the metabolic properties of these exciting cells. In this study, proton (1H) NMR spectroscopy was used to identify the major low-molecular-weight metabolites in murine embryonic stem cells (ESC) and their neural stem cell (NSC) derivatives. ESC are characterized by an unusually low number of NMR-detectable metabolites, high phosphocholine (PC) content, and nondetectable glycerophosphocholine (GPC). The metabolic profiles of NSC resemble glial cells and oligodendrocyte progenitors, but with considerably higher PC, GPC, and myo-inositol content. The results suggest that NMR spectroscopy in vitro can provide markers to study the effects of differentiation on cell metabolism, and potentially to assess stem cell preparations for differentiation status., (Copyright (c) 2006 Wiley-Liss, Inc.)
- Published
- 2006
- Full Text
- View/download PDF
43. Human embryoid body-derived stem cells in tissue engineering-enhanced migration in co-culture with bladder smooth muscle and urothelium.
- Author
-
Frimberger D, Morales N, Gearhart JD, Gearhart JP, and Lakshmanan Y
- Subjects
- Cells, Cultured, Humans, Cell Movement, Muscle, Smooth cytology, Stem Cells, Tissue Engineering, Urinary Bladder cytology, Urothelium cytology
- Abstract
Objectives: To evaluate the affinity between human stem cells and human bladder cells by analyzing their migration and proliferation patterns in co-culture. Human stem cells have great potential for tissue engineering purposes. Co-culture of stem cells with mature cells may promote differentiation., Methods: Equal numbers of green fluorescent protein-labeled human embryonic germ cell derivates (SDECs) were plated, either alone or in the presence of red fluorescence-labeled (PKH 26) human bladder smooth muscle cells (SMCs) or urothelial cells (UROs). The co-cultures shared the same media (EGM2MV). The migration patterns of the different cell lines were measured daily, using an integrated grid, for 8 days with fluorescence microscopy., Results: SDECs, grown alone, had a robust basal migration rate of between 0.3 and 0.7 mm/day compared with SMCs, which had a rate of 0.1 to 0.3 mm/day and UROs with a rate of 0.1 to 0.2 mm/day. Stem cell migration was enhanced in co-culture with SMCs or UROs to 0.5 to 1.0 mm/day. Migration of SDECs was more linear, directed toward SMCs or UROs, compared with the circumferential growth when plated alone. SMCs, more than UROs, migrated more rapidly in the presence of stem cells., Conclusions: Human stem cells showed improved migration in the presence of mature human bladder cells and were attracted to them, as shown by the altered direction of growth. Thus, co-culture of human stem cells with host SMCs can enhance seeding of matrices due to positive chemotaxis. Identifying the responsible factors may help to augment chemotaxis between desired cell types and optimize tissue regeneration.
- Published
- 2006
- Full Text
- View/download PDF
44. Pluripotent stem cells from germ cells.
- Author
-
Kerr CL, Shamblott MJ, and Gearhart JD
- Subjects
- Animals, Cell Culture Techniques methods, Humans, Adult Stem Cells, Germ Cells, Pluripotent Stem Cells
- Abstract
To date, stem cells have been derived from three sources of germ cells. These include embryonic germ cells (EGCs), embryonal carcinoma cells (ECCs), and multipotent germ line stem cells (GSCs). EGCs are derived from primordial germ cells that arise in the late embryonic and early fetal period of development. ECCs are derived from adult testicular tumors whereas GSCs have been derived by culturing spermatogonial stem cells from mouse neonates and adults. For each of these lines, their pluripotency has been demonstrated by their ability to differentiate into cell types derived from the three germ layers in vitro and in vivo and in chimeric animals, including germ line transmission. These germ line-derived stem cells have been generated from many species including human, mice, porcine, and chicken albeit with only slight modifications. This chapter describes general considerations regarding critical aspects of their derivation compared with their counterpart, embryonic stem cells (ESCs). Detailed protocols for EGC derivation and maintenance from human and mouse primordial germ cells (PGCs) will be presented.
- Published
- 2006
- Full Text
- View/download PDF
45. Human embryonic stem cells.
- Author
-
Wilmut I, West MD, Lanza RP, Gearhart JD, Smith A, Colman A, Trounson AO, and Campbell KH
- Subjects
- Animals, Blastocyst cytology, Cell Line, Humans, Nuclear Transfer Techniques, Cloning, Organism, Embryo, Mammalian cytology, Stem Cells
- Published
- 2005
- Full Text
- View/download PDF
46. Transplanted human embryonic germ cell-derived neural stem cells replace neurons and oligodendrocytes in the forebrain of neonatal mice with excitotoxic brain damage.
- Author
-
Mueller D, Shamblott MJ, Fox HE, Gearhart JD, and Martin LJ
- Subjects
- Animals, Animals, Newborn, Apoptosis drug effects, Apoptosis physiology, Brain Damage, Chronic chemically induced, Brain Damage, Chronic physiopathology, Caspase 3, Caspases metabolism, Cell Differentiation physiology, Cell Line, Cell Proliferation, Disease Models, Animal, Germ Cells cytology, Germ Cells physiology, Graft Survival physiology, Humans, Mice, Mice, Inbred C57BL, Nerve Degeneration chemically induced, Nerve Degeneration physiopathology, Nerve Degeneration therapy, Neurons cytology, Neurotoxins, Nitric Oxide Synthase metabolism, Oligodendroglia cytology, Prosencephalon cytology, Prosencephalon physiology, Prosencephalon surgery, Stem Cell Transplantation trends, Stem Cells cytology, Treatment Outcome, Brain Damage, Chronic therapy, Germ Cells transplantation, Neurons physiology, Oligodendroglia physiology, Stem Cell Transplantation methods, Stem Cells physiology
- Abstract
Stem cell therapy is a hope for the treatment of some childhood neurological disorders. We examined whether human neural stem cells (hNSCs) replace lost cells in a newborn mouse model of brain damage. Excitotoxic lesions were made in neonatal mouse forebrain with the N-methyl-D-aspartate (NMDA) receptor agonist quinolinic acid (QA). QA induced apoptosis in neocortex, hippocampus, striatum, white matter, and subventricular zone. This degeneration was associated with production of cleaved caspase-3. Cells immunopositive for inducible nitric oxide synthase were present in damaged white matter and subventricular zone. Three days after injury, mice received brain parenchymal or intraventricular injections of hNSCs derived from embryonic germ (EG) cells. Human cells were prelabeled in vitro with DiD for in vivo tracking. The locations of hNSCs within the mouse brain were determined through DiD fluorescence and immunodetection of human-specific nestin and nuclear antigen 7 days after transplantation. hNSCs survived transplantation into the lesioned mouse brain, as evidenced by human cell markers and DiD fluorescence. The cells migrated away from the injection site and were found at sites of injury within the striatum, hippocampus, thalamus, and white matter tracts and at remote locations in the brain. Subsets of grafted cells expressed neuronal and glial cell markers. hNSCs restored partially the complement of striatal neurons in brain-damaged mice. We conclude that human EG cell-derived NSCs can engraft successfully into injured newborn brain, where they can survive and disseminate into the lesioned areas, differentiate into neuronal and glial cells, and replace lost neurons. (c) 2005 Wiley-Liss, Inc.
- Published
- 2005
- Full Text
- View/download PDF
47. Human embryoid body-derived stem cells in co-culture with bladder smooth muscle and urothelium.
- Author
-
Lakshmanan Y, Frimberger D, Gearhart JD, and Gearhart JP
- Subjects
- Animals, Cell Line, Cells, Cultured, Humans, Intestinal Mucosa cytology, Intestine, Small cytology, Pilot Projects, Swine, Tissue Culture Techniques, Cell Culture Techniques methods, Muscle, Smooth cytology, Stem Cells physiology, Urothelium cytology
- Abstract
Objectives: Human pluripotent stem cells have excellent regenerative abilities, making them attractive in bladder regeneration. Porcine small intestinal submucosa (SIS) is an established matrix well-suited to the urinary tract. We evaluated the ability of human embryonic germ (hEG) cell-derived stem cells to form a composite graft on SIS, grown alone or in combination with human bladder smooth muscle cells (SMCs) or urothelial (URO) cells., Methods: The hEG cell-derived cell line SDEC had the best-fit profile for smooth muscle, as determined by its gene and protein expression. SDEC cells were seeded on SIS, either on its serosal or mucosal surface, and cultured for 7 or 14 days. Co-cultures of stem cells with URO cells or SMCs were also assessed under similar conditions. The grafts were analyzed by histologic examination for cell growth, morphology, and matrix penetration., Results: SDEC cells grew in a monolayer on SIS, with a marked increase in three-dimensional growth when co-cultured with URO cells or SMCs. Penetration of the matrix was evident when seeded on the rough surface of the SIS, progressing with time. Stratification of the cell layers occurred on the smooth side of the SIS., Conclusions: This is the first description of hEG cell-derived stem cells in co-culture with bladder cells. hEG cell-derived stem cells grow well on SIS even when seeded at low concentrations in the presence of bladder cells (URO cells or SMCs). These composite grafts will be ideal to evaluate the in vivo functional characteristics of stem cells using an animal model of bladder regeneration.
- Published
- 2005
- Full Text
- View/download PDF
48. Human embryoid body-derived stem cells in bladder regeneration using rodent model.
- Author
-
Frimberger D, Morales N, Shamblott M, Gearhart JD, Gearhart JP, and Lakshmanan Y
- Subjects
- Animals, Cell Line, Models, Animal, Rats, Rats, Nude, Stem Cell Transplantation, Tissue Culture Techniques, Regeneration, Stem Cells physiology, Urinary Bladder physiology
- Abstract
Objectives: To evaluate the capability of a human embryonic germ (hEG) cell-derived cell line (SDEC), previously characterized in our laboratory, seeded on porcine small intestinal submucosa (SIS) to regenerate the injured rat bladder., Methods: Fluorescent-labeled SDEC cells seeded on SIS for 8 days in vitro were used as bladder grafts in rats. A total of 30 congenitally athymic rats (six groups of 5 rats each), underwent partial cystectomy and replacement with plain SIS (groups 1 to 3) or cell-seeded SIS (groups 4 to 6). The rats were sacrificed after 7 (groups 1 and 4), 14 (groups 2 and 5), and 28 (groups 3 and 6) days. The bladders were analyzed by histopathologic examination and fluorescence microscopy., Results: No graft rejection or diminution in bladder capacity occurred. Plain SIS implants had multiple calcareous deposits, not seen with the cell-seeded implants. Macroscopically, at 7 days, the grafts were healed with a cellular lining on the luminal aspect in groups 4 to 6. Microscopically, the rat bladder was completely regenerated 28 days after stem cell-seeded SIS implantation. Labeled stem cells were identified throughout the graft and contributed significantly to bladder regeneration., Conclusions: The results of this study have demonstrated the successful replacement of a bladder defect in a rat model using hEG cell-derived cells seeded on SIS grafts. Longer term analysis of these bladder grafts will allow evaluation of function, cell migration, and differentiation processes of human stem cells.
- Published
- 2005
- Full Text
- View/download PDF
49. Bone morphogenetic proteins produced by cells within embryoid bodies inhibit ventral directed differentiation by Sonic Hedgehog.
- Author
-
Sterneckert JL, Hill CM, Palmer R, and Gearhart JD
- Subjects
- Animals, Body Patterning, Bone Morphogenetic Protein 7, Bone Morphogenetic Proteins metabolism, Carrier Proteins metabolism, Cell Differentiation, Cells, Cultured, Coculture Techniques, Culture Techniques, Embryonic Induction, Hedgehog Proteins, Homeobox Protein Nkx-2.2, Homeodomain Proteins metabolism, Mice, Mitosis, Neurons cytology, Protein Structure, Tertiary, Reverse Transcriptase Polymerase Chain Reaction, Spinal Cord embryology, Stem Cells cytology, Time Factors, Transcription Factors metabolism, Transcription, Genetic, Transforming Growth Factor beta metabolism, Tretinoin metabolism, Tretinoin pharmacology, Zebrafish Proteins, Bone Morphogenetic Proteins biosynthesis, Embryo, Mammalian cytology, Gene Expression Regulation, Developmental, Trans-Activators metabolism
- Abstract
Mouse embryoid bodies (EBs) differentiate into dorsal spinal cord neural progenitors in response to retinoic acid (RA). Our data demonstrate that the addition of Sonic Hedgehog (Shh) directs towards a ventral spinal cord neural tube fate, but only at extremely high concentrations. One possible explanation is the presence of dorsal directing factors. Bone morphogenetic proteins (BMPs), known to direct dorsal spinal cord neural differentiation, were expressed in RA-treated EBs. Shh more potently directed ventral differentiation when combined with the BMP inhibitor Noggin. Further, when BMP7 was added, the ability of Shh to direct ventral differentiation was further mitigated.
- Published
- 2005
- Full Text
- View/download PDF
50. Facts on stem cells.
- Author
-
Faden RR and Gearhart JD
- Subjects
- Embryo Research ethics, Embryo, Mammalian cytology, Federal Government, Financing, Government, Government Regulation, Humans, Politics, Research Support as Topic, United States, Embryo Research legislation & jurisprudence, Stem Cells
- Published
- 2004
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.